Literature DB >> 15149299

Quality of life and its correlates in patients with bipolar disorder stabilized on lithium prophylaxis.

Prabhat K Chand1, Surendra K Mattoo, Pratap Sharan.   

Abstract

The quality of life (QOL) of 50 bipolar disorder patients in remission (stabilized on lithium prophylaxis) was assessed and compared with that of clinically stable patients with schizophrenia (n = 20) and healthy subjects (n = 20). World Health Organization Quality of Life-Bref (WHOQOL-BREF) and Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q) were used to assess QOL in the three groups of subjects. The factors that contribute or influence QOL (i.e. stressful life events, social support, daily hassles) were also studied using standardized instruments in the study group. It was found that, compared to schizophrenia group, the bipolar group had significantly better QOL in all the domains of Q-LES-Q and the domains of general well-being, physical health and psychological health of the WHOQOL-Bref. The bipolar group had similar QOL scores in all other domains and higher scores in leisure time activity domain of Q-LES-Q, in comparison to the healthy group. The QOL in the bipolar group was better in patients who were younger and had a lesser severity of daily hassle. The present findings suggest that euthymic patients with bipolar disorder have a QOL that is comparable to that of healthy subjects. In contrast, patients with clinically stable schizophrenia have a poorer QOL. Occurrence of daily hassles contributes significantly to QOL in patients with bipolar disorder. However, the relatively limited variance explained by the independent variables included in the study, suggests the need to examine other (perhaps non-clinical) factors that may affect QOL.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15149299     DOI: 10.1111/j.1440-1819.2004.01237.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  16 in total

1.  What does the WHOQOL-Bref measure? Measurement overlap between quality of life and depressive symptomatology in chronic somatoform pain disorder.

Authors:  Martin Aigner; Sophie Förster-Streffleur; Wolfgang Prause; Marion Freidl; Maria Weiss; Michael Bach
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-01-01       Impact factor: 4.328

Review 2.  Posttraumatic stress disorder, depression, and health-related quality of life in patients with bipolar disorder: review and new data from a multi-site community clinic sample.

Authors:  Laura A Bajor; Zongshan Lai; David E Goodrich; Christopher J Miller; Robert B Penfold; Hyungjin Myra Kim; Mark S Bauer; Amy M Kilbourne
Journal:  J Affect Disord       Date:  2012-09-27       Impact factor: 4.839

3.  Quality of life of 'normal' controls: association with lifetime history of mental illness.

Authors:  Dianne Schechter; Jean Endicott; John Nee
Journal:  Psychiatry Res       Date:  2007-03-23       Impact factor: 3.222

Review 4.  Burden of bipolar depression: impact of disorder and medications on quality of life.

Authors:  Erin E Michalak; Greg Murray; Allan H Young; Raymond W Lam
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

5.  Relationship of hope, sense of community, and quality of life.

Authors:  Ed Stevens; Mayra Guerrero; Austin Green; Leonard A Jason
Journal:  J Community Psychol       Date:  2018-02-24

6.  Changes in Quality of Life following Buprenorphine Treatment: Relationship with Treatment Retention and Illicit Opioid Use.

Authors:  Shannon Gwin Mitchell; Jan Gryczynski; Robert P Schwartz; C Patrick Myers; Kevin E O'Grady; Yngvild K Olsen; Jerome H Jaffe
Journal:  J Psychoactive Drugs       Date:  2015 Apr-Jun

7.  Treatment outcomes among a cohort of African American buprenorphine patients: Follow-up at 12 months.

Authors:  Laura B Monico; Jan Gryczynski; Robert P Schwartz; Jerome H Jaffe; Kevin E O'Grady; Shannon Gwin Mitchell
Journal:  Am J Drug Alcohol Abuse       Date:  2018-05-02       Impact factor: 3.829

8.  Measuring severe adverse events and medication selection using a "PEER Report" for nonpsychotic patients: a retrospective chart review.

Authors:  Daniel A Hoffman; Charles Debattista; Robert J Valuck; Dan V Iosifescu
Journal:  Neuropsychiatr Dis Treat       Date:  2012-06-21       Impact factor: 2.570

9.  Indian psychiatry: Research and international perspectives.

Authors:  Roy Abraham Kallivayalil; Rakesh K Chadda; Juan E Mezzich
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

10.  Quality of life in bipolar type I disorder in a one-year followup.

Authors:  Homayoun Amini; Vandad Sharifi
Journal:  Depress Res Treat       Date:  2012-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.